Preventing Central Catheter-Associated Bloodstream Infections

Overview

The research is an algorithm study focused on nursing care in order to prevent Central Catheter-Associated Bloodstream Infections in intensive care units. The algorithm prepared with infection control measures related to central catheter care will be applied with intensive care nurses and the effect of the algorithm on central catheter-related bloodstream infections will be examined. In practice, a 20-day preliminary assessment, a three-month intervention period, and a three-month post-intervention planning were made.

Full Title of Study: “APPLICATION OF NURSE-FOCUSED ALGORITHM IN INTENSIVE CARE UNITS TO PREVENT CENTRAL CATHETER-RELATED BLOODSTREAM ─░NFECT─░ONS”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Prevention
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 31, 2021

Detailed Description

In the light of literature review and guidelines, intensive care nurses will care for central catheters through an algorithm created with infection control measures. Nurse-focused algorithm content to prevent central catheter-related bloodstream infections Hand hygiene practice Use of personal protective equipment according to infection control measures Evaluation of the catheter insertion site in terms of redness, swelling, tenderness, discharge, bleeding Use of >0.5% chlorhexidine solution containing 70% alcohol for skin antisepsis at the catheter insertion site (if there is no chlorhexidine, povidone iodine + 70% alcohol solution is used) Changing the transparent, semi-permeable dressings every 5-7 days and gauze dressings every 48 hours for catheter dressing Catheter dressing with aseptic technique Use of sterile, preservative-free saline for flushing and locking in order to ensure the lumen of the catheter. Aseptic conditions should be observed if the junction of the catheter and the infusion set (Hub) is to be touched. Keeping the used triple taps closed Changing IV fluid sets and connection tools at appropriate times Daily assessment of CVC requirement The research will be carried out in the 1st, 2nd and 3rd Level Intensive Care Units of Bilecik Training and Research Hospital in Bilecik, Turkey. Infection rates will be compared in the study. In the study, the date of June 2021 will be taken as a preliminary assessment and training time for nurses. July-September 2021 will be the intervention period of the study, and October-December 2021 will be the post-intervention period.

Interventions

  • Other: Infection Prevention
    • Preventing central catheter-related bloodstream infections in intensive care units

Arms, Groups and Cohorts

  • Experimental: Central catheter-related bloodstream infection rates in intensive care units

Clinical Trial Outcome Measures

Primary Measures

  • Infection rate
    • Time Frame: Three months
    • Central catheter-related bloodstream infection rates in intensive care units

Participating in This Clinical Trial

Inclusion Criteria

  • A central venous catheter was inserted in the intensive care unit or before the intensive care unit admission, and being followed up in the intensive care unit with a central venous catheter. Exclusion Criteria:

  • Patients whose central venous catheter was terminated during intensive care follow-up.

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 100 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Abant Izzet Baysal University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Aysun ACUN, Research Assistant – Gazi University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.